Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Endevica spinout Kalohexis submits confidential IPO filing to develop obesity challenger to GLP-1s

Endevica spinout Kalohexis submits confidential IPO filing to develop obesity challenger to GLP-1s

  • July 7, 2026

Clinical-stage Kalohexis is readying a public listing to support its obesity and cancer cachexia treatments.

Leave A Comment

Fields (*) Mark are Required